Please log in to determine if you are eligible to purchase PT Programs.
NAVIGATING BIOMODALITY BIOMARKERS ADTL - NMB1
NMB1
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Cases per Mailing Number of Shipments
Multimodality biomarker assessment case analysis 2 Two online acitivites per year

Biomarkers can be tested through a variety of methodologies (eg, immunohistochemistry, flow cytometry, next generation sequencing, PCR-based testing, karyotype, FISH, clinical chemistry, etc.). Each modality has different technical strengths and weaknesses, along with varied analytical and clinical specifications such as sensitivity and specificity. Results may not be clearly concordant across the modalities. This program will challenge pathologists to resolve discrepancies between different methods or “multimodality” biomarker testing.


Program Information

  • Reporting option with CME or CE credit for each additional pathologist or laboratory professional (within the same institution); must order in conjunction with program NMBA
  • Earn a maximum of 4 CME credits (AMA PRA Category 1 Credits) per pathologist and a maximum of 4 CE credits per laboratory professional per year.
  • This activity meets the ABPath CC requirements for Improvement in Medical Practice (IMP).
  • Your CAP shipping contact will be notified via email when the activity is available

Shipping Schedule

  • Shipment A: April 1
  • Shipment B: November 18






Customers Who Bought This Item Also Bought
NAVIGATING BIOMODALITY BIOMARKERS
VIEW DETAILS >